Formulary IQ synthesizes your drug acquisition cost, utilization patterns, patient specific reimbursement, and clinical evidence to recommend the right medication at the right site of care, across inpatient and outpatient settings.
No team can keep pace with all of them by hand. InpharmD watches every signal, every day, across every drug class.
New drugs, new indications, and new generic and biosimilar entrants launch every quarter, each with its own evidence and economics.
Guidelines, label updates, and head-to-head trial data are revised constantly. What was first-line last quarter may not be today.
Step-therapy rules, prior-auth criteria, and contract terms change throughout the year across hundreds of plans.
WAC, ASP, 340B, and rebate dynamics swing margin per encounter, often without notice.
Identify the financially preferred, clinically supported therapy in seconds.
Covered products and viable therapies surface from real payer data, so teams acton coverage reality, not assumptions
A fast, flexible way to measure overall performance.
Run full financial analysis on any formulary change built on your actual cost,reimbursement and utilization data.
Inpatient interchange recommendations built on your cost and utilization data, informed by decisions across InpharmD's network of health systems.